Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Orient Bio Inc Announces Amendments to Rights Issue


Thursday, 14 Mar 2013 04:38am EDT 

Orient Bio Inc announced that it has made amendments to the previously announced rights issue of 20 million common shares. After the amendments, the shareholders will have rights to purchase new rights shares from May 8, 2013 to May 9, 2013 and the listing date of the new shares will be May 31, 2013. KRW 5,971,517,533 of the proceeds will be used for its facilities, KRW 1,743,482,467 will be used for its operations and KRW 2,285 million will be used as other funds. 

Company Quote

590.0
-1.0 -0.17%
2:00am EDT